Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
JBCHEPHARM
₹2,506
₹2380.00
₹2525.50
₹1638.50
₹2525.50
Markets Today
Historical Performance
As of 25-08-2026 01:28, J B Chemicals & Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-2506.00 (-100.00%) from the previous close of ₹2506. The stock opened at ₹2506 and traded between ₹2380 and ₹2525.5, with a total traded volume of 4779224 shares. The company has a market capitalization of ₹38677 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2525.5 and ₹1638.5, respectively.
J B Chemicals & Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 54.5, EPS of ₹45.16, and book value of ₹9.30. Profitability indicators show ROE of 17.05% along with a dividend yield of 0.9%. J B Chemicals & Pharmaceuticals Ltd. has reported revenue of ₹4147.79 Cr and net profit of ₹709.46 Cr.
J B Chemicals & Pharmaceuticals Ltd. technical indicators include Day RSI at 60.96, Day MFI at 54.28, Day ADX at 41.17. Additional indicators include Commodity Channel Index (CCI) at 72.5 and Williams %R at -40.32. Momentum indicators show Day MACD at 72.22, Day MACD Signal Line at 65.64, DayATR at 59.79. Rate of Change indicators for J B Chemicals & Pharmaceuticals Ltd. include ROC125 at 27.55 and ROC21 at 9.85.
Exponential moving averages include EMA5 at ₹2448.9, EMA10 at ₹2423.4, EMA12 at ₹2411.1, EMA20 at ₹2366.3, EMA26 at ₹2338.9, EMA50 at ₹2259.7, EMA100 at ₹2154.1, EMA200 at ₹2025.6. Simple moving averages include SMA5 at ₹2459.6, SMA10 at ₹2435.5, SMA20 at ₹2344.3, SMA30 at ₹2296.3, SMA50 at ₹2241.4, SMA100 at ₹2142, SMA150 at ₹2046.4, SMA200 at ₹1965.9.
Support levels for J B Chemicals are placed at First Support ₹2350.77, Second Support ₹2292.63, Third Support ₹2205.27. Resistance levels are seen at First Resistance ₹2496.27, Second Resistance ₹2583.63, Third Resistance ₹2641.77. J B Chemicals & Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 48.8%, FII holding at 16.33%, DII holding at 0%, public holding at 13.48%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 836.43 | 990.91 | 1,022.65 | 1,039.90 | 901.34 |
| Operating Expense | 641.50 | 721.41 | 724.29 | 746.78 | 670.36 |
| Operating Profit | 194.93 | 269.50 | 298.36 | 293.12 | 230.98 |
| Depreciation | 48.56 | 43.62 | 43.11 | 41.40 | 44.41 |
| Interest | 1.33 | 1.59 | 1.01 | 0.66 | 0.93 |
| Tax | 31.56 | 61.91 | 68.07 | 67.09 | 49.37 |
| Net Profit | 96.54 | 179.27 | 200.42 | 197.87 | 149.80 |
₹2506.00
↗ Bullish Moving Average
11
↘ Bearish Moving Average
5
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 53.7 | 47.8 | 47.7 | 47.6 | 47.6 | 48.8 |
| FII | 14.6 | 18.3 | 17.8 | 15.3 | 14.9 | 16.3 |
| DII | 16.4 | 18.7 | 19.6 | 22.8 | 23.3 | 21.4 |
| Public | 15.3 | 15.1 | 14.9 | 14.3 | 14.2 | 13.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 0 | 0 | undefined% |
| Week | 0 | 0 | undefined% |
| 1 Month | 0 | 0 | undefined% |
| 6 Month | 2.04 L | 3.23 L | 63.25% |
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 29 May, 2026 | 9.3 | FINAL | 29 May, 2026 | Equity Share |
| 11 Feb, 2026 | 12.7 | INTERIM | 11 Feb, 2026 | Equity Share |
| 30 Jul, 2025 | 7 | FINAL | 30 Jul, 2025 | Equity Share |
| 07 Feb, 2025 | 8.5 | INTERIM | 08 Feb, 2025 | Equity Share |
| 14 Aug, 2024 | 6.75 | FINAL | 14 Aug, 2024 | Equity Share |
| 16 Feb, 2024 | 5.5 | INTERIM | 16 Feb, 2024 | Equity Share |
| 17 Aug, 2023 | 9.25 | FINAL | Equity Share | |
| 17 Feb, 2023 | 8.5 | INTERIM | 18 Feb, 2023 | Equity Share |
| 12 Aug, 2022 | 8 | FINAL | Equity Share | |
| 23 Feb, 2022 | 8.5 | INTERIM | 24 Feb, 2022 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,766 | ₹883.60 | ₹1,436.80 | ₹1,862 | ₹2,374.50 | ₹212.43 |
| % Change | 2.39% | 1.39% | -1.41% | -0.05% | -0.40% | -0.58% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 99.10 | 85.20 | 85.50 | 34.90 | 48.20 | -90.70 |
| 1 Year Return | 255.61 | 5.9 | 57.4 | 24.77 | -8.55 | 10.85 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Acutaas Chemicals Ltd.
₹ 3171.00
+0.06%
Gland Pharma Ltd.
₹ 2811.90
-0.26%
Laurus Labs Ltd.
₹ 1801.00
-0.06%
Alkem Laboratories Ltd.
₹ 5350.00
-0.93%
Biocon Ltd.
₹ 409.40
-1.48%
Divi's Laboratories Ltd.
₹ 8496.00
-1.17%
Granules India Ltd.
₹ 857.00
-0.13%
Ajanta Pharma Ltd.
₹ 3581.00
-1.62%
Zydus Lifesciences Ltd.
₹ 1103.80
-1.45%
Glenmark Pharmaceuticals Ltd.
₹ 2390.70
+3.14%
Wockhardt Ltd.
₹ 1902.00
+0.83%
Aurobindo Pharma Ltd.
₹ 1608.00
-0.82%
Sun Pharmaceutical Industries Ltd.
₹ 1910.00
+0.40%
Neuland Laboratories Ltd.
₹ 22901.00
-1.72%
Ipca Laboratories Ltd.
₹ 1921.00
+0.51%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2930.00
+0.96%
Pfizer Ltd.
₹ 4886.00
-1.85%
Abbott India Ltd.
₹ 26450.00
+0.84%
Torrent Pharmaceuticals Ltd.
₹ 4886.50
-0.20%
Lupin Ltd.
₹ 2188.00
-0.63%
Dr. Reddy's Laboratories Ltd.
₹ 1190.00
+1.30%
Cipla Ltd.
₹ 1437.90
+0.40%
By signing up I certify terms, conditions & privacy policy